These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25200121)

  • 21. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
    Curry MP; Forns X; Chung RT; Terrault NA; Brown R; Fenkel JM; Gordon F; O'Leary J; Kuo A; Schiano T; Everson G; Schiff E; Befeler A; Gane E; Saab S; McHutchison JG; Subramanian GM; Symonds WT; Denning J; McNair L; Arterburn S; Svarovskaia E; Moonka D; Afdhal N
    Gastroenterology; 2015 Jan; 148(1):100-107.e1. PubMed ID: 25261839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C treatment: an incipient therapeutic revolution.
    deLemos AS; Chung RT
    Trends Mol Med; 2014 Jun; 20(6):315-21. PubMed ID: 24636306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sofosbuvir as backbone of interferon free treatments.
    Bourlière M; Oules V; Ansaldi C; Adhoute X; Castellani P
    Dig Liver Dis; 2014 Dec; 46 Suppl 5():S212-20. PubMed ID: 25453869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging options for treating hepatitis C infection.
    Fantasia HC
    Nurs Womens Health; 2015; 19(2):183-7. PubMed ID: 25900589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chronic hepatitis C. Interferon free therapy also in patients with liver cirrhosis].
    MMW Fortschr Med; 2014 Dec; 156(21-22):97. PubMed ID: 25608420
    [No Abstract]   [Full Text] [Related]  

  • 26. Simeprevir for hepatitis C virus.
    Hutcheson S; Klibanov OM
    Nurse Pract; 2014 Sep; 39(9):10-2. PubMed ID: 25140845
    [No Abstract]   [Full Text] [Related]  

  • 27. [A new era in therapy of chronic hepatitis C].
    Füessl HS
    MMW Fortschr Med; 2015 Feb; 157(2):38. PubMed ID: 25743515
    [No Abstract]   [Full Text] [Related]  

  • 28. Advances in and the future of treatments for hepatitis C.
    Cheng R; Tu T; Shackel N; McCaughan GW
    Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):633-47. PubMed ID: 24846594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase IIa, open-label study.
    Moreno C; Berg T; Tanwandee T; Thongsawat S; Van Vlierberghe H; Zeuzem S; Lenz O; Peeters M; Sekar V; De Smedt G
    J Hepatol; 2012 Jun; 56(6):1247-53. PubMed ID: 22326470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution of simeprevir-resistant variants over time by ultra-deep sequencing in HCV genotype 1b.
    Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Ikeda K; Kumada H
    J Med Virol; 2014 Aug; 86(8):1314-22. PubMed ID: 24797623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sofosbuvir (Sovaldi) for hepatitis C virus.
    Lomberk M; Klibanov OM
    Nurse Pract; 2015 Sep; 40(9):16-9. PubMed ID: 26274882
    [No Abstract]   [Full Text] [Related]  

  • 32. [New combination therapy increases chances of recovery].
    Jäger-Becker D
    MMW Fortschr Med; 2015 Feb; 157(3):70. PubMed ID: 25743682
    [No Abstract]   [Full Text] [Related]  

  • 33. The impact of the new antiviral regimens on patient reported outcomes and health economics of patients with chronic hepatitis C.
    Younossi Z; Henry L
    Dig Liver Dis; 2014 Dec; 46 Suppl 5():S186-96. PubMed ID: 25458773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic viral hepatitis. Treatment progress, hopes for cures.
    Mayo Clin Health Lett; 2014 Mar; 32(3):4-5. PubMed ID: 24696905
    [No Abstract]   [Full Text] [Related]  

  • 35. Daclatasvir for the treatment of hepatitis C virus infection.
    Adler H; Lambert JS
    Expert Rev Gastroenterol Hepatol; 2014 Sep; 8(7):725-38. PubMed ID: 24882552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chronic hepatitis C infection--eradication of the virus].
    Ben Ari Z
    Harefuah; 2014 Jul; 153(7):392-3, 433. PubMed ID: 25189028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global origin and transmission of hepatitis C virus nonstructural protein 3 Q80K polymorphism.
    McCloskey RM; Liang RH; Joy JB; Krajden M; Montaner JS; Harrigan PR; Poon AF
    J Infect Dis; 2015 Apr; 211(8):1288-95. PubMed ID: 25389307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Boceprevir and telaprevir in the management of hepatitis C virus-infected patients.
    Butt AA; Kanwal F
    Clin Infect Dis; 2012 Jan; 54(1):96-104. PubMed ID: 22156853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus: here comes all-oral treatment.
    Dugum M; O'Shea R
    Cleve Clin J Med; 2014 Mar; 81(3):159-72. PubMed ID: 24591471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of sofosbuvir-based therapies in HIV/HCV infected patients and persons who inject drugs.
    Puoti M; Panzeri C; Rossotti R; Baiguera C
    Dig Liver Dis; 2014 Dec; 46 Suppl 5():S206-11. PubMed ID: 25458781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.